Jove
Visualize
Contact Us

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-genotoxic transplantation and in vivo selection through epitope editing.

Nature·2026
Same author

Genetic Medicine - Primed and Ready.

The New England journal of medicine·2026
Same author

Nucleotide-resolution mapping of regulatory elements via allelic readout of tiled base editing.

Nature communications·2026
Same author

Analyzing long-read CRISPR experiments with CRISPRLungo.

bioRxiv : the preprint server for biology·2025
Same author

The XPO7-NPAT axis represents key vulnerabilities in TP53-mutated acute myeloid leukemia.

Blood·2025
Same author

Direct and indirect regulation of fetal globin transcript by RNA-binding protein IGF2BP1.

bioRxiv : the preprint server for biology·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 23, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

5.1K

A genome editing primer for the hematologist.

Megan D Hoban1, Daniel E Bauer1

  • 1Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA; and Department of Pediatrics, Harvard Medical School, Harvard Stem Cell Institute, Boston, MA.

Blood
|April 8, 2016
PubMed
Summary

Gene editing technologies allow precise genome modification for hematology research and treating blood disorders. These powerful tools offer new ways to improve cellular therapies and understand genetic functions.

More Related Videos

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

4.5K
Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
08:14

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on: October 3, 2019

13.1K

Related Experiment Videos

Last Updated: Mar 23, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

5.1K
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

4.5K
Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
08:14

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on: October 3, 2019

13.1K

Area of Science:

  • Molecular Biology
  • Genetics
  • Hematology

Background:

  • Gene editing technologies enable precise genomic alterations.
  • These tools are increasingly used in experimental hematology.
  • Genome editing shows promise for treating genetic blood disorders and enhancing cellular therapies.

Purpose of the Study:

  • To review current gene editing technologies.
  • To discuss their advantages and limitations in hematology.
  • To explore future applications of genome editing in the field.

Main Methods:

  • Review of scientific literature on gene editing techniques.
  • Analysis of applications in experimental hematology.
  • Discussion of potential therapeutic uses for blood disorders.

Main Results:

  • Gene editing, including epigenome editing, offers versatile approaches for genetic modification.
  • Site-specific double-strand breaks and nicks are key mechanisms.
  • Various outcomes can be achieved depending on the editing strategy.

Conclusions:

  • Gene editing technologies are rapidly advancing and becoming integral to hematology.
  • They hold significant potential for both research and clinical applications in treating blood disorders.
  • Future prospects for genome editing in hematology are substantial.